Framingham, MA, United States of America

Douglas McClure

USPTO Granted Patents = 2 

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 7(Granted Patents)


Company Filing History:


Years Active: 2022-2024

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations by Douglas McClure

Introduction

Douglas McClure is an accomplished inventor based in Framingham, MA (US). He has made significant contributions to the field of healthcare technology, particularly in the area of disease management. With a total of two patents to his name, McClure is dedicated to improving the lives of patients through innovative solutions.

Latest Patents

One of McClure's latest patents is an integrated disease management system. This system provides patients with simple, quick, and readily available counseling regarding a healthy diabetic lifestyle. It includes an interactive engine with predictive analytics and machine learning to offer a customized experience for users. The system is designed to transmit data to a remote server for analysis, providing feedback to users based on their data and interactions. Additionally, it can send curated content to other user devices or remote health management access points, allowing healthcare stakeholders to access vital information.

Career Highlights

McClure is currently employed at Embecta Corp., where he continues to develop innovative healthcare solutions. His work focuses on integrating technology with patient care to enhance the management of chronic diseases.

Collaborations

Some of McClure's notable coworkers include Michael Hoar and Rita Saltiel-Berzin. Their collaboration fosters a creative environment that drives innovation within the company.

Conclusion

Douglas McClure's contributions to healthcare technology through his patents and work at Embecta Corp. highlight his commitment to improving patient outcomes. His innovative approaches are paving the way for more effective disease management solutions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…